Structure Therapeutics (GPCR) Preferred Stock Liabilities (2022)

Structure Therapeutics' Preferred Stock Liabilities history runs 1 years deep, the most recent figure standing at $200.0 million for Q4 2022.

• In Q4 2022, Preferred Stock Liabilities changed N/A year-over-year to $200.0 million; the TTM figure through Dec 2022 stood at $200.0 million (changed N/A YoY), while the FY2022 annual figure was $200.0 million, changed N/A from the prior year.
• Preferred Stock Liabilities for Q4 2022 stood at $200.0 million.
• The five-year high for Preferred Stock Liabilities was $200.0 million in Q4 2022, with the low at $200.0 million in Q4 2022.